Healing hormone provides hope for brain injury
If Don Stein were the kind of man who listened to what others said, he would have shut down his lab years ago. The Emory neuroscientist spent more than two decades investigating progesterone as a treatment ...
Medical research
Apr 24, 2013 |
4.3 / 5 (4) |
0
Seasonal changes may influence the efficacy of vaccination against diabetes
The development of a medicine for patients with type 1 diabetes mellitus, based on autoantigen GAD65, received a setback following crucial clinical phase 3 trials that failed to show significant effects. One possible explanation ...
Diabetes
Feb 01, 2012 |
5 / 5 (1) |
0
Newly approved oral medication slows rheumatoid arthritis joint damage
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX). Results of the 12-month ...
Arthritis & Rheumatism
Jan 24, 2013 |
5 / 5 (1) |
0
New medication shows promise as lipid-lowering therapy for rare cholesterol disorder
An international effort led by researchers at the Perelman School of Medicine at the University of Pennsylvania has resulted in positive phase 3 clinical trial results for a new medicine to treat patients suffering from a ...
Medical research
Nov 02, 2012 |
4 / 5 (1) |
0
|
